Details
Stereochemistry | RACEMIC |
Molecular Formula | C18H18N4O2 |
Molecular Weight | 322.3611 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(CC1=CC=CC=C1)[N+]2=NOC([N-]C(=O)NC3=CC=CC=C3)=C2
InChI
InChIKey=OWFUPROYPKGHMH-UHFFFAOYSA-N
InChI=1S/C18H18N4O2/c1-14(12-15-8-4-2-5-9-15)22-13-17(24-21-22)20-18(23)19-16-10-6-3-7-11-16/h2-11,13-14H,12H2,1H3,(H-,19,20,21,23)
Molecular Formula | C18H19N4O2 |
Molecular Weight | 323.3691 |
Charge | 1 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Mesocarb (sydnocarb or 3-(beta-phenylisopropyl)-N-phenylcarbamoylsydnonimine) is a psychomotor stimulant N-alkylated amphetamine derivative. Mesocarb is a selective inhibitor of dopamine uptake, it potently blocks dopamine transporter. It is very likely that mesocarb is being used by drug addicts. Mesocarb is included in the World Anti-Doping Agency’s list of substances and methods that are prohibited in sports. It is used in Russia for the treatment of a variety of neuropsychiatric comorbidities.
CNS Activity
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: Q01959 Gene ID: 6531.0 Gene Symbol: SLC6A3 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/21300706 |
8.3 nM [Ki] |
Sample Use Guides
The drug is administered orally, before meals, 1-2 times a day in the first half of the day. Adults: initial dose of 0.005 g / day; if necessary - up to 0,015-0,05 g / day; maintenance dose - 0.005-0.01 g / day, the highest single dose - 0.075 g, daily - 0.15 g
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 17:23:10 GMT 2023
by
admin
on
Sat Dec 16 17:23:10 GMT 2023
|
Record UNII |
UMT8MP2NDU
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
DEA NO. |
1227
Created by
admin on Sat Dec 16 17:23:10 GMT 2023 , Edited by admin on Sat Dec 16 17:23:10 GMT 2023
|
||
|
NCI_THESAURUS |
C66884
Created by
admin on Sat Dec 16 17:23:10 GMT 2023 , Edited by admin on Sat Dec 16 17:23:10 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
100000081166
Created by
admin on Sat Dec 16 17:23:10 GMT 2023 , Edited by admin on Sat Dec 16 17:23:10 GMT 2023
|
PRIMARY | |||
|
71932
Created by
admin on Sat Dec 16 17:23:10 GMT 2023 , Edited by admin on Sat Dec 16 17:23:10 GMT 2023
|
PRIMARY | |||
|
CHEMBL2105246
Created by
admin on Sat Dec 16 17:23:10 GMT 2023 , Edited by admin on Sat Dec 16 17:23:10 GMT 2023
|
PRIMARY | |||
|
UMT8MP2NDU
Created by
admin on Sat Dec 16 17:23:10 GMT 2023 , Edited by admin on Sat Dec 16 17:23:10 GMT 2023
|
PRIMARY | |||
|
DTXSID10900961
Created by
admin on Sat Dec 16 17:23:10 GMT 2023 , Edited by admin on Sat Dec 16 17:23:10 GMT 2023
|
PRIMARY | |||
|
SUB08785MIG
Created by
admin on Sat Dec 16 17:23:10 GMT 2023 , Edited by admin on Sat Dec 16 17:23:10 GMT 2023
|
PRIMARY | |||
|
3865
Created by
admin on Sat Dec 16 17:23:10 GMT 2023 , Edited by admin on Sat Dec 16 17:23:10 GMT 2023
|
PRIMARY | |||
|
C009257
Created by
admin on Sat Dec 16 17:23:10 GMT 2023 , Edited by admin on Sat Dec 16 17:23:10 GMT 2023
|
PRIMARY | |||
|
C83937
Created by
admin on Sat Dec 16 17:23:10 GMT 2023 , Edited by admin on Sat Dec 16 17:23:10 GMT 2023
|
PRIMARY | |||
|
MESOCARB
Created by
admin on Sat Dec 16 17:23:10 GMT 2023 , Edited by admin on Sat Dec 16 17:23:10 GMT 2023
|
PRIMARY | |||
|
34262-84-5
Created by
admin on Sat Dec 16 17:23:10 GMT 2023 , Edited by admin on Sat Dec 16 17:23:10 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
|
||
|
ENANTIOMER -> RACEMATE |
|
||
|
ENANTIOMER -> RACEMATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|